Recommended Topic Related To:

Aranesp

"The U.S. Food and Drug Administration approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs). For patients with cancer, the program "...

Aranesp

OVERDOSE

Aranesp overdosage can cause hemoglobin levels above the desired level, which should be managed with discontinuation or reduction of Aranesp dosage and/or with phlebotomy, as clinically indicated [see Pharmacodynamics]. Cases of severe hypertension have been observed following overdose with ESAs [see WARNINGS AND PRECAUTIONS].

CONTRAINDICATIONS

Aranesp is contraindicated in patients with:

  • Uncontrolled hypertension [see WARNINGS AND PRECAUTIONS].
  • Pure red cell aplasia (PRCA) that begins after treatment with Aranesp or other erythropoietin protein drugs [see WARNINGS AND PRECAUTIONS].
  • Serious allergic reactions to Aranesp [see WARNINGS AND PRECAUTIONS].

Last reviewed on RxList: 1/27/2014
This monograph has been modified to include the generic and brand name in many instances.

A A A

Aranesp - User Reviews

Aranesp User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Aranesp sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.